Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 4777 - 4784 of 11616 results
Want To Avoid Costly Patent Cases? Amazon Offers A Hack
May 2, 2019| News
Land of Tax Opportunity Zones II
May 1, 2019| Alert| Viewpoint
Update on FDA’s Comprehensive Regenerative Medicine Policies and Enforcement Activities
April 29, 2019| Blog| Viewpoint
Fourth Circuit Strikes Down Federal Debt-Collection Exemption to the TCPA
April 29, 2019| Alert| Viewpoint
MLS Weekly Preview: Medicare For All Gets a Hearing
April 29, 2019| Blog| Viewpoint
FTC Alleges Surescripts Illegally Monopolized E-Prescription Market
April 29, 2019| Alert| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.